* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Scott M. Hendler
Associate General Counsel
Greenwich, Connecticut
5/16/2022
This restatement of the Reporting Person's Form 13F for Q4 2021 is being filed to adjust the aggregate amount of shares (and corresponding market value) of the position in Ginkgo Bioworks Holdings Inc. to add the unvested earn-out shares which have been issued to the Reporting Person but are subject to forfeiture.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.